chlorthalidone has been researched along with Body Weight in 52 studies
Chlorthalidone: A benzenesulfonamide-phthalimidine that tautomerizes to a BENZOPHENONES form. It is considered a thiazide-like diuretic.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One hundred seventy-one patients, 60 years of age or older with isolated systolic hypertension, were randomly assigned to receive chlorthalidone 12." | 9.06 | Isolated systolic hypertension in the elderly. A placebo-controlled, dose-response evaluation of chlorthalidone. ( Aranda, J; Barra, P; Davidov, M; Ettinger, B; Gorwit, J; McBarron, F; Morledge, JH, 1986) |
| "Seventy-one patients with mild-to-moderate essential hypertension completed 14 weeks' treatment with a single daily dose of fixed combination of metoprolol tartrate 100 mg and chlorthalidone 25 mg (Logroton; Geigy)." | 9.05 | A fixed combination of metoprolol and chlorthalidone in hypertension. A clinical trial in general practice. ( Govind, U; Munro, BF; Robertson, LI, 1981) |
| "After a control period on a placebo, 45 patients with mild to moderate hypertension were treated with metoprolol, 100 mg twice daily alone and in free combination with chlorthalidone 50 mg daily using a double-blind crossover technique." | 9.04 | Metoprolol with and without chlorthalidone in hypertension. ( Ebbutt, A; John, V; Kendall, M; Kubik, M, 1979) |
| " Group A: In 14 patients with essential hypertension on chlorthalidone treatment, an additional daily dose of 640 mg propranolol for two months led to a significant reduction of the MAP (from 124 to 105 mm Hg) and PRA (from 5." | 9.04 | Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension. ( Boer, P; Geyskes, GG; Leenen, FH; Mees, EJ; Vos, J, 1975) |
| "The effects of chlorthalidone and metoprolol on fasting plasma lipids and lipoprotein levels were compared in two similar nonrandomized groups of patients with mild hypertension." | 7.67 | Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status. ( Goldbourt, U; Holtzman, E; Rosenthal, T; Segal, P, 1984) |
| "We evaluated the effect of additional chlorthalidone therapy on blood pressure and body fluid volumes in 10 patients with essential hypertension who did not respond to chronic converting enzyme inhibition with enalapril." | 7.67 | Changes in blood pressure and body fluid volumes during diuretic therapy in patients with essential hypertension who receive enalapril. ( Geyskes, GG; Mees, EJ; Roos, JC; van Schaik, BA, 1986) |
| "Intrarenal handling of uric acid was studied in 12 patients with essential hypertension under spironolactone treatment (200 mg/day)." | 7.66 | Changes in intrarenal uric acid handling during chronic spironolactone treatment in patients with essential hypertension. ( Boer, P; Dorhout Mees, EJ; Peuker, KH; Roos, JC, 1982) |
| "In 50 patients with essential hypertension treated with chlorthalidone, 100 mg daily for 6 weeks, treatment responders (fall in mean pressure, greater than or equal to 10%) and nonresponders experienced similar weight and electrolyte changes." | 7.65 | Disparate patterns of aldosterone response during diuretic treatment of hypertension. ( Drayer, JI; Laragh, JH; Rev, A; Weber, MA, 1977) |
| "Treatment with propranolol resulted in marked suppression of the plasma renin activity (1." | 6.64 | Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension. ( Benraad, TJ; Drayer, JI; Festen, J; Kloppenborg, PW; van't Laar, A, 1975) |
| "Amiloride and chlorthalidone pretreatment induced marked volume depletion, with a 2-3% reduction in body weight, a 5-10% increase in haematocrit and a 14-23% increase in plasma colloid osmotic pressure." | 5.11 | Foot volume increase on nifedipine is not prevented by pretreatment with diuretics. ( Huysmans, FT; van der Heijden, AG; van Hamersvelt, HW, 2004) |
| "One hundred seventy-one patients, 60 years of age or older with isolated systolic hypertension, were randomly assigned to receive chlorthalidone 12." | 5.06 | Isolated systolic hypertension in the elderly. A placebo-controlled, dose-response evaluation of chlorthalidone. ( Aranda, J; Barra, P; Davidov, M; Ettinger, B; Gorwit, J; McBarron, F; Morledge, JH, 1986) |
| "Seventy-one patients with mild-to-moderate essential hypertension completed 14 weeks' treatment with a single daily dose of fixed combination of metoprolol tartrate 100 mg and chlorthalidone 25 mg (Logroton; Geigy)." | 5.05 | A fixed combination of metoprolol and chlorthalidone in hypertension. A clinical trial in general practice. ( Govind, U; Munro, BF; Robertson, LI, 1981) |
| "After a control period on a placebo, 45 patients with mild to moderate hypertension were treated with metoprolol, 100 mg twice daily alone and in free combination with chlorthalidone 50 mg daily using a double-blind crossover technique." | 5.04 | Metoprolol with and without chlorthalidone in hypertension. ( Ebbutt, A; John, V; Kendall, M; Kubik, M, 1979) |
| " Group A: In 14 patients with essential hypertension on chlorthalidone treatment, an additional daily dose of 640 mg propranolol for two months led to a significant reduction of the MAP (from 124 to 105 mm Hg) and PRA (from 5." | 5.04 | Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension. ( Boer, P; Geyskes, GG; Leenen, FH; Mees, EJ; Vos, J, 1975) |
| "The effects of chlorthalidone and metoprolol on fasting plasma lipids and lipoprotein levels were compared in two similar nonrandomized groups of patients with mild hypertension." | 3.67 | Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status. ( Goldbourt, U; Holtzman, E; Rosenthal, T; Segal, P, 1984) |
| "We evaluated the effect of additional chlorthalidone therapy on blood pressure and body fluid volumes in 10 patients with essential hypertension who did not respond to chronic converting enzyme inhibition with enalapril." | 3.67 | Changes in blood pressure and body fluid volumes during diuretic therapy in patients with essential hypertension who receive enalapril. ( Geyskes, GG; Mees, EJ; Roos, JC; van Schaik, BA, 1986) |
| "Intrarenal handling of uric acid was studied in 12 patients with essential hypertension under spironolactone treatment (200 mg/day)." | 3.66 | Changes in intrarenal uric acid handling during chronic spironolactone treatment in patients with essential hypertension. ( Boer, P; Dorhout Mees, EJ; Peuker, KH; Roos, JC, 1982) |
| "Twenty-four patients with hypertension were treated with chlorothiazide, chlorthalidone, and frusemide." | 3.66 | Duration of effect of different diuretics. ( Adam, WR; Hodgson, N; Morgan, TO; Myers, J, 1979) |
| "In 79 patients with essential hypertension, treatment with propranolol hydrochloride and chlorthalidone together produced significantly greater falls in both systolic and diastolic blood pressures than were obtained with either drug alone." | 3.65 | Renin reactivity as a determinant of responsiveness to antihypertensive treatment. ( Case, DB; Drayer, JI; Laragh, JH; Lopez-Ovejero, JA; Weber, MA, 1977) |
| "In 50 patients with essential hypertension treated with chlorthalidone, 100 mg daily for 6 weeks, treatment responders (fall in mean pressure, greater than or equal to 10%) and nonresponders experienced similar weight and electrolyte changes." | 3.65 | Disparate patterns of aldosterone response during diuretic treatment of hypertension. ( Drayer, JI; Laragh, JH; Rev, A; Weber, MA, 1977) |
| "Treatment with propranolol resulted in marked suppression of the plasma renin activity (1." | 2.64 | Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension. ( Benraad, TJ; Drayer, JI; Festen, J; Kloppenborg, PW; van't Laar, A, 1975) |
| "Chlorthalidone was given to one group during all 20 days of DOCA administration (preventive regimen) and to another group 20 days after DOCA treatment was initiated until the 40th day (therapeutic regimen)." | 1.29 | Effects of chlorthalidone on ventricular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats. ( Cabral, AM; Carvalhinho, FB; Cicilini, MA; Vasquez, EC, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 47 (90.38) | 18.7374 |
| 1990's | 4 (7.69) | 18.2507 |
| 2000's | 1 (1.92) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GESSLER, U | 1 |
| NEUHAUS, M | 1 |
| CRANSTON, WI | 1 |
| JUEL-JENSEN, BE | 1 |
| SEMMENCE, AM | 1 |
| JONES, RP | 1 |
| FORBES, JA | 1 |
| MUTCH, LM | 1 |
| SIEGENTHALER, P | 1 |
| HALLER, J | 1 |
| HALLER, R | 1 |
| HAMPAI, A | 1 |
| MULLER, AF | 1 |
| MOGGIAN, G | 1 |
| ZANARDI, E | 1 |
| SAMSON, WE | 1 |
| van der Heijden, AG | 1 |
| Huysmans, FT | 1 |
| van Hamersvelt, HW | 1 |
| Johnston, LC | 1 |
| Grieble, HG | 1 |
| Webb, EL | 1 |
| Godfrey, JC | 1 |
| Rosenbaum, R | 1 |
| Zisblatt, M | 1 |
| Vukovich, RA | 1 |
| Neiss, ES | 1 |
| Holtzman, E | 1 |
| Rosenthal, T | 1 |
| Goldbourt, U | 1 |
| Segal, P | 1 |
| Goldman, AI | 1 |
| Steele, BW | 1 |
| Schnaper, HW | 1 |
| Fitz, AE | 1 |
| Frohlich, ED | 1 |
| Perry, HM | 1 |
| Govind, U | 1 |
| Munro, BF | 1 |
| Robertson, LI | 1 |
| Roos, JC | 2 |
| Boer, P | 2 |
| Peuker, KH | 1 |
| Dorhout Mees, EJ | 1 |
| Käch, O | 1 |
| Hochuli, E | 1 |
| Cabral, AM | 1 |
| Carvalhinho, FB | 1 |
| Vasquez, EC | 1 |
| Cicilini, MA | 1 |
| Wylie-Rosett, J | 1 |
| Wassertheil-Smoller, S | 2 |
| Blaufox, MD | 2 |
| Davis, BR | 1 |
| Langford, HG | 2 |
| Oberman, A | 3 |
| Jennings, S | 1 |
| Hataway, H | 1 |
| Stern, J | 1 |
| Zimbaldi, N | 1 |
| Haris, A | 1 |
| Radó, JP | 1 |
| Leemhuis, MP | 1 |
| van Damme, KJ | 1 |
| Struyvenberg, A | 1 |
| MacGregor, GA | 1 |
| Tasker, PR | 1 |
| de Wardener, HE | 1 |
| Patzschke, U | 1 |
| Manegold, C | 1 |
| Wolff, G | 1 |
| Pinals, RS | 1 |
| Dalakos, TG | 1 |
| Streeten, DH | 1 |
| Tweeddale, MG | 1 |
| Ogilvie, RI | 1 |
| Ruedy, J | 1 |
| Weidmann, P | 1 |
| De Chătel, R | 1 |
| Ziegler, WH | 1 |
| Flammer, J | 1 |
| Reubi, F | 1 |
| Kubik, M | 1 |
| Kendall, M | 1 |
| Ebbutt, A | 1 |
| John, V | 1 |
| Morgan, TO | 1 |
| Adam, WR | 1 |
| Hodgson, N | 1 |
| Myers, J | 1 |
| Weber, MA | 2 |
| Lopez-Ovejero, JA | 1 |
| Drayer, JI | 3 |
| Case, DB | 1 |
| Laragh, JH | 2 |
| Fagard, R | 1 |
| Amery, A | 1 |
| Lijnen, P | 1 |
| Reybrouck, T | 1 |
| Rev, A | 1 |
| Hunyor, SN | 1 |
| Zweifler, AJ | 1 |
| Hansson, L | 1 |
| Schork, MA | 1 |
| Ellis, C | 1 |
| Geyskes, GG | 2 |
| Vos, J | 1 |
| Leenen, FH | 1 |
| Mees, EJ | 2 |
| Kloppenborg, PW | 1 |
| Festen, J | 1 |
| van't Laar, A | 1 |
| Benraad, TJ | 1 |
| Davis, B | 1 |
| Langford, H | 1 |
| Fasano, ML | 1 |
| Soro, S | 1 |
| Ferrara, LA | 1 |
| van Schaik, BA | 1 |
| Morledge, JH | 1 |
| Ettinger, B | 1 |
| Aranda, J | 1 |
| McBarron, F | 1 |
| Barra, P | 1 |
| Gorwit, J | 1 |
| Davidov, M | 2 |
| Costa, FV | 1 |
| Borghi, C | 1 |
| Mussi, A | 1 |
| Ambrosioni, E | 1 |
| Heyden, S | 1 |
| Borhani, NO | 1 |
| Tyroler, HA | 1 |
| Schneider, KA | 1 |
| Hames, CG | 1 |
| Hutchinson, R | 1 |
| Greenwald, SE | 1 |
| Berry, CL | 1 |
| Ramsey, RE | 1 |
| Floyd, DB | 1 |
| Domenet, JG | 1 |
| Guazzi, M | 1 |
| Polese, A | 1 |
| Fiorentini, C | 1 |
| Magrini, F | 1 |
| Bengtsson, C | 2 |
| Fotiu, S | 1 |
| Mroczek, WJ | 1 |
| Finnerty, FA | 1 |
| Richardson, DW | 1 |
| Freund, J | 1 |
| Gear, AS | 1 |
| Mauck, HP | 1 |
| Preston, LW | 1 |
| Toubes, DB | 1 |
| McIntosh, TJ | 1 |
| Kirkendall, WM | 1 |
| Wilson, WR | 1 |
| Tervilä, L | 1 |
| Vartiainen, E | 1 |
| Sung, PK | 1 |
| Samet, P | 1 |
| Yeh, BK | 1 |
| Katz, FH | 1 |
| Eckert, RC | 1 |
| Gebott, MD | 1 |
| Graudenz, MG | 1 |
| Andersen, JB | 1 |
| Schoeppe, W | 1 |
| Koch, KM | 1 |
| Kaul, A | 1 |
| Hierholzer, K | 1 |
| Bergström, J | 1 |
| Hultman, E | 1 |
| Freis, ED | 1 |
| Sappington, RF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000513] | Phase 3 | 0 participants | Interventional | 1984-04-30 | Completed | ||
| [NCT00005122] | 0 participants | Observational | 1958-07-31 | Completed | |||
| [NCT00000485] | Phase 3 | 0 participants | Interventional | 1971-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
27 trials available for chlorthalidone and Body Weight
| Article | Year |
|---|---|
Foot volume increase on nifedipine is not prevented by pretreatment with diuretics.
Topics: Adult; Amiloride; Ankle; Body Weight; Calcium Channel Blockers; Chlorthalidone; Diuretics; Edema; Fe | 2004 |
Chlorthalidone-triamterene: a potassium-sparing diuretic combination for the treatment of oedema.
Topics: Adult; Aged; Body Weight; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Drug Combin | 1984 |
Serum lipoprotein levels during chlorthalidone therapy. A Veterans Administration-National Heart, Lung, and Blood Institute cooperative study on antihypertensive therapy: mild hypertension.
Topics: Adult; Blood Glucose; Blood Pressure; Body Weight; Chlorthalidone; Cholesterol; Clinical Trials as T | 1980 |
A fixed combination of metoprolol and chlorthalidone in hypertension. A clinical trial in general practice.
Topics: Adult; Blood Pressure; Body Weight; Chlorthalidone; Clinical Trials as Topic; Drug Combinations; Fun | 1981 |
Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention.
Topics: Adult; Analysis of Variance; Atenolol; Blood Pressure; Body Weight; Chlorthalidone; Combined Modalit | 1993 |
Patterns of potassium wasting in response to stepwise combinations of diuretics in nephrotic syndrome.
Topics: Aged; Amiloride; Body Weight; Chlorthalidone; Diuresis; Diuretics; Drug Therapy, Combination; Female | 1999 |
Antihypertensive and biochemical effects of chlorthalidone.
Topics: Antihypertensive Agents; Blood Chemical Analysis; Blood Pressure; Body Weight; Chlorthalidone; Clini | 1977 |
Alpha and beta adrenergic blockade with orally administered labetalol in hypertension. Studies on blood volume, plasma renin and aldosterone and catecholamine excretion.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Blood Volume; Body Weight; Chlorthalidone; Clinical Trials | 1978 |
Metoprolol with and without chlorthalidone in hypertension.
Topics: Adult; Blood Pressure; Body Weight; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combinat | 1979 |
Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume.
Topics: Adult; Aldosterone; Body Weight; Chlorthalidone; Female; Humans; Hypertension; Male; Middle Aged; Pl | 1975 |
Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Bromine; Chlorthalidone; Clinical Trials as Topic; Diet, S | 1975 |
Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension.
Topics: Adult; Aldosterone; Blood Pressure; Body Weight; Chlorthalidone; Clinical Trials as Topic; Creatinin | 1975 |
The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Body Weight; Cardiovascular Diseases | 1992 |
Long-term antihypertensive efficacy of ketanserin plus chlorthalidone.
Topics: Adult; Aged; Blood Pressure; Body Weight; Chlorthalidone; Clinical Trials as Topic; Drug Administrat | 1989 |
Isolated systolic hypertension in the elderly. A placebo-controlled, dose-response evaluation of chlorthalidone.
Topics: Age Factors; Aged; Blood Glucose; Body Weight; Chlorthalidone; Cholesterol; Clinical Trials as Topic | 1986 |
Cadralazine and chlorthalidone as a second-step drug with atenolol in hypertensive patients: differences in blood pressure control during exercise.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Chemical Analysis; Blood Pressure; Body Weight; Chlo | 1986 |
The relationship of weight change to changes in blood pressure, serum uric acid, cholesterol and glucose in the treatment of hypertension.
Topics: Blood Glucose; Blood Pressure; Body Weight; Chlorthalidone; Cholesterol; Clinical Trials as Topic; D | 1985 |
The relationship of weight change to changes in blood pressure, serum uric acid, cholesterol and glucose in the treatment of hypertension.
Topics: Blood Glucose; Blood Pressure; Body Weight; Chlorthalidone; Cholesterol; Clinical Trials as Topic; D | 1985 |
The relationship of weight change to changes in blood pressure, serum uric acid, cholesterol and glucose in the treatment of hypertension.
Topics: Blood Glucose; Blood Pressure; Body Weight; Chlorthalidone; Cholesterol; Clinical Trials as Topic; D | 1985 |
The relationship of weight change to changes in blood pressure, serum uric acid, cholesterol and glucose in the treatment of hypertension.
Topics: Blood Glucose; Blood Pressure; Body Weight; Chlorthalidone; Cholesterol; Clinical Trials as Topic; D | 1985 |
Chlorthalidone in the treatment of angina pectoris.
Topics: Aged; Angina Pectoris; Body Weight; Chlorthalidone; Clinical Trials as Topic; Female; Humans; Male; | 1973 |
Comparison between alprenolol and chlorthalidone as antihypertensive agents.
Topics: Adult; Alprenolol; Amino Alcohols; Blood Pressure; Body Weight; Chlorthalidone; Clinical Trials as T | 1972 |
Long-term effect of alprenolol as antihypertensive agent.
Topics: Adult; Airway Obstruction; Alprenolol; Blood Pressure; Body Weight; Chlorthalidone; Clinical Trials | 1974 |
Antihypertensive efficacy of metolazone.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Body Weight; Chlorthalidone; Diuretics; Edema; | 1974 |
Effect of propranolol on elevated arterial blood pressure.
Topics: Adult; Aged; Antihypertensive Agents; Bilirubin; Blood Cell Count; Blood Pressure; Blood Urea Nitrog | 1968 |
Hypotensive effects of clonidine and chlorthalidone. Controlled clinical trial of drugs administered singly and in combination.
Topics: Alkaline Phosphatase; Antihypertensive Agents; Aspartate Aminotransferases; Bilirubin; Blood Glucose | 1971 |
The effects and side effects of diuretics in the prophylaxis of toxaemia of pregnancy.
Topics: Adult; Birth Weight; Blood Urea Nitrogen; Body Height; Body Weight; Chlorthalidone; Clinical Trials | 1971 |
Effects of clonidin and chlorthalidone on blood pressure and glucose tolerance in hypertensive patients.
Topics: Adult; Aged; Aniline Compounds; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; | 1971 |
The effect of thiazides, chlorthalidone and furosemide on muscle electrolytes and muscle glycogen in normal subjects.
Topics: Body Weight; Chlorthalidone; Diuresis; Diuretics; Furosemide; Glycogen; Humans; Muscles; Water-Elect | 1966 |
Long-term effect of probenecid on diuretic-induced hyperuricemia.
Topics: Adult; Aged; Blood Chemical Analysis; Blood Pressure Determination; Body Weight; Chlorthalidone; Hum | 1966 |
25 other studies available for chlorthalidone and Body Weight
| Article | Year |
|---|---|
[Experimental studies on intracellular and extracellular changes in electrolyte and water content after chlorthalidone treatment].
Topics: Body Weight; Chlorthalidone; Electrolytes; Heart; Kidney; Liver; Muscles; Water; Water-Electrolyte B | 1962 |
EFFECTS OF ORAL DIURETICS ON RAISED ARTERIAL PRESSURE.
Topics: Arterial Pressure; Bendroflumethiazide; Benzothiadiazines; Blood; Blood Pressure Determination; Body | 1963 |
EFFECT OF EXPERIMENTAL SALT DEPLETION AND ALDOSTERONE LOAD ON SODIUM AND CHLORIDE CONCENTRATION IN THE SWEAT OF PATIENTS WITH CYSTIC FIBROSIS OF THE PANCREAS AND OF NORMAL CHILDREN.
Topics: Adolescent; Aldosterone; Biochemical Phenomena; Biochemistry; Body Weight; Child; Chlorides; Chlorth | 1964 |
[CLINICAL EXPERIENCES ON THE ACTION OF HYGROTON IN PREGNANCY TOXEMIAS].
Topics: Adolescent; Biomedical Research; Body Weight; Body Weights and Measures; Chlorthalidone; Drug Therap | 1964 |
CLINICAL EVALUATION OF POLYTHIAZIDE IN HYPERTENSION AND CONGESTIVE HEART FAILURE: A COMPARATIVE DOUBLE-BLIND STUDY.
Topics: Biomedical Research; Blood Chemical Analysis; Blood Pressure; Body Weight; Chlorthalidone; Diuresis; | 1965 |
Treatment of arterial hypertensive disease with diuretics. V. Spironolactone, an aldosterone antagonist.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Body Weight; Chlorthalidone; Female; Humans; Hyperaldost | 1967 |
Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status.
Topics: Body Weight; Chlorthalidone; Cholesterol; Coronary Disease; Female; Heart Rate; Humans; Hypertension | 1984 |
Changes in intrarenal uric acid handling during chronic spironolactone treatment in patients with essential hypertension.
Topics: Body Weight; Chlorthalidone; Female; Humans; Hypertension; Kidney; Male; Spironolactone; Uric Acid | 1982 |
[Diuretics during pregnancy - controversy or option? (author's transl)].
Topics: Body Weight; Chlorthalidone; Female; Humans; Pre-Eclampsia; Pregnancy | 1981 |
Effects of chlorthalidone on ventricular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Cardiomegaly; Chlorthalidone; Desoxycorticosterone; Dose-Respo | 1994 |
Effects of chlorthalidone on serum and total body potassium in hypertensive patients.
Topics: Adult; Antihypertensive Agents; Body Weight; Chlorthalidone; Drug Therapy, Combination; Electrolytes | 1976 |
Diuretic-induced oedema.
Topics: Adult; Aldosterone; Blood Volume; Body Weight; Chlorthalidone; Diuretics; Edema; Female; Furosemide; | 1975 |
[Reduction of hypertensive changes in the electrocardiogram during antihypertensive treatment].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Body Weight; Chlorthalidone; Electrocardiography; Fe | 1979 |
Idiopathic edema as a cause of nonarticular rheumatism.
Topics: Adult; Body Weight; Capillary Permeability; Chlorthalidone; Dextroamphetamine; Edema; Female; Humans | 1979 |
Duration of effect of different diuretics.
Topics: Aged; Biological Availability; Blood Pressure; Body Weight; Chlorothiazide; Chlorthalidone; Female; | 1979 |
Renin reactivity as a determinant of responsiveness to antihypertensive treatment.
Topics: Adult; Aged; Aldosterone; Antihypertensive Agents; Blood Pressure; Body Weight; Chlorthalidone; Drug | 1977 |
Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.
Topics: Adult; Angiotensin II; Blood Pressure; Body Weight; Chlorthalidone; Diet, Sodium-Restricted; Female; | 1977 |
Disparate patterns of aldosterone response during diuretic treatment of hypertension.
Topics: Adult; Aldosterone; Body Weight; Chlorthalidone; Female; Humans; Hypertension; Male; Middle Aged; Pu | 1977 |
Changes in blood pressure and body fluid volumes during diuretic therapy in patients with essential hypertension who receive enalapril.
Topics: Aged; Aldosterone; Blood Pressure; Body Fluids; Body Weight; Chlorthalidone; Creatinine; Drug Evalua | 1986 |
The static elastic properties and chemical composition of the rat aorta in spontaneously occurring and experimentally induced hypertension: the effect of an anti-hypertensive drug.
Topics: Aging; Animals; Aorta; Aorta, Abdominal; Aorta, Thoracic; Body Weight; Chlorthalidone; Collagen; Ela | 1985 |
Importance of the adrenergic nervous system in the support of cardiac function in patients with primary arterial hypertension.
Topics: Body Weight; Cardiac Output; Chlorthalidone; Digitalis Glycosides; Glomerular Filtration Rate; Guane | 1973 |
Hypokalemia caused by surreptitious self-administration of diuretics.
Topics: Adjustment Disorders; Adult; Bicarbonates; Body Weight; Chlorides; Chlorthalidone; Chromatography, T | 1972 |
[Use of chlorthalidone in patients using oral contraceptives].
Topics: Adult; Body Weight; Chlorthalidone; Contraceptives, Oral; Edema; Epilepsy; Female; Headache; Humans; | 1969 |
The effect of diuretics in late pregnancy on the newborn infant.
Topics: Bendroflumethiazide; Body Fluids; Body Weight; Chlorides; Chlorthalidone; Deuterium; Electrolytes; E | 1970 |
[Studies on potassium distribution and determination of total body potassium by measurement of K40].
Topics: Body Weight; Chlorthalidone; Erythrocytes; Female; Humans; Middle Aged; Potassium; Potassium Isotope | 1965 |